We report that Ber upregulates MHC-I expression on the surface of melanoma cells, thereby enhancing antigen presentation and the subsequent recognition and elimination of tumor cells by CD8+ T cells, circumventing tumor immune escape. Here, CD8A is linked to neoplasm.